Skip to content

BofA ‘Bull & Bear’ indicator hints at further extreme bearishness

BofA 'Bull & Bear' indicator hints at further extreme bearishness
Dino Kurbegovic

The S&P 500 entered a bear market officially on June 13, making it the 20th bear market the index has experienced in the past 140 years. 

Meanwhile, the financial market sentiment indicator dubbed the “bull & bear” index and calculated by Bank of America (NYSE: BAC) continues to point to extreme bearishness in the markets. On June 17, the indicator hit 0 for the first time and has remained there for four consecutive weeks.  

Bull & Bear index. Source: MarketWatch

This bearishness is best evidenced by increased outflows of funds from equities, as global outflows have reached $5.8 billion for stocks and $17 billion for bonds, with an additional outflow of $1.1 billion from gold. 

Bank of America strategists led by Michael Hartnett, in a client note, sent out on July 1, wrote:

“In Q2’22 commodity gains moderated (8.4% vs 35.0% in Q1)…”inflation shock” consensus, big gains in US$ (6.9%), big losses govt bonds (-9.5%), massive losses crypto (Bitcoin -58.1%)…”rates shock” begins, accelerated losses in credit (HY -10.9% vs -6.0%) & stocks (-14.6% vs -5.3%)…”recession shock” begins; key asset prices H2 = depth of recession given “credit shock” & geopolitical risks.”

Sour sentiment 

Pundits agree that a bear market is official when an index loses roughly 20% of its value compared to its most recent all-time high, and throughout history, bear markets last 289 days. Though history is not a guide to future performance, the current bear market could end on October 19, 2022, as per Bank of America analysts. 

On the other hand, market participants often times use the BofA indicator to gauge when to buy their favorite stocks. Namely, readings below 2.0 signal buy while 0 signals oversold conditions and extreme bearishness. 

Sometimes, it pays well to be a contrarian investor and buy when the market points to oversold conditions.  

Buy stocks now with Interactive Broker – the most advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.  

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.